Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Human urate transporter 1 (URAT1, SLC22A12) is an integral membrane protein localized in the apical membrane of renal proximal tubule epithelial cells. It operates as an antiporter, exchanging intracellular organic anions or chloride ions for extracellular urate, thus crucially controlling urate reabsorption into the bloodstream. The transporter’s activity depends on a network of highly conserved amino acid residues that form a hydrophobic binding pocket, ensuring selective urate transport, and undergoes conformational changes between inward, outward, and occluded states during the transport cycle. This mechanism can be pharmacologically inhibited, and several drugs target URAT1 directly to lower serum urate, making it a prime target for treating gout and hyperuricemia. Genetic variations in URAT1 can influence urate affinity and transport efficiency, potentially affecting drug response and disease risk.
Pharmacological inhibition of urate reabsorption (reducing serum urate by blocking URAT1; drug binding interferes with urate or counteranion binding in the transport cycle)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human urate transporter 1 (URAT1).